CBT

Cabot Corporation 10-Q Summary: Quarter Ended December 31, 2003

Business Context and Reporting Period

This filing is a Quarterly Report (Form 10-Q) for Cabot Corporation for the three-month period ended December 31, 2003 (First Quarter of Fiscal 2004). Cabot is a specialty chemicals company operating primarily through three segments: Chemical Business, Cabot Supermetals, and Specialty Fluids. The company is incorporated in Delaware and maintains its principal executive offices in Boston, Massachusetts.

Key Financial Metrics

Note: Total debt calculated as Notes payable to banks ($21M) + Current portion of long-term debt ($40M) + Long-term debt ($517M).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 9% to $446 million, driven by higher prices, improved product mix, and favorable foreign exchange in the Chemical Business segment.
• Profitability Decline: Despite revenue growth, Net Income decreased 12% to $29 million. Segment profit before tax dropped 16% to $46 million, primarily due to a 34% decline in the Cabot Supermetals segment profit caused by lower intermediate product sales.
• Operating Cash Flow Improvement: Cash provided by operating activities surged to $48 million compared to a $1 million outflow in the prior year, attributed to reduced receivables and inventory levels.
• Discontinued Operations: The current quarter included a $1 million after-tax loss from discontinued operations related to litigation on a previously divested business, whereas the prior year had no such items.

Guidance, Outlook, and Risks

Management Outlook: Management expresses cautious optimism regarding economic recovery. They anticipate cost savings initiatives in the Chemical Business will offset margin pressure from raw material costs. The Supermetals outlook is improving due to strengthening electronics demand, and Specialty Fluids is expected to improve as new drilling jobs commence.

Restructuring: Cabot initiated a European restructuring plan in May 2003. Total estimated pre-tax charges are approximately $64 million. As of December 31, 2003, $47 million has been recorded, with an additional $8 million expected over the next 12-18 months. This includes the closure of a carbon black facility in Spain and workforce reductions.

Significant Risks and Contingencies:

• Respirator Litigation: Approximately 90,000 pending claims related to safety respiratory products acquired from American Optical Corporation. A $20 million reserve has been established.
• Environmental Matters: A $26 million reserve exists for environmental remediation, primarily related to divested businesses.
• Beryllium Litigation: Ongoing lawsuits regarding personal injury from former beryllium operations in Reading, Pennsylvania. Recent appellate court decisions have reversed dismissals in some cases, returning them to trial.
• Antitrust Actions: Class action lawsuits alleging price-fixing in the carbon black market in Kansas, South Dakota, and Tennessee.

Investor Verification Checklist

• Restructuring Execution: Verify the timeline and actual costs associated with the $64 million European restructuring plan, specifically the closure of the Zierbena, Spain facility.
• Supermetals Recovery: Monitor the recovery of the Cabot Supermetals segment, which saw a 34% profit decline, to ensure the anticipated demand in the electronics market materializes.
• Litigation Reserves: Assess the adequacy of the $20 million respirator liability reserve and the $26 million environmental reserve given the high volume of pending claims (90,000 respirator cases).
• Raw Material Costs: Track the impact of rising feedstock costs on the Chemical Business margins, as price increases have not fully offset these costs.
• Capital Expenditures: Confirm the $130 million capital expenditure plan for Fiscal 2004, including the $3 million commitment to the new fumed silica joint venture in China.